IL-33 Induces a Hyporesponsive Phenotype in Human and Mouse Mast Cells
- 15 January 2013
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 190 (2), 531-538
- https://doi.org/10.4049/jimmunol.1201576
Abstract
IL-33 is elevated in afflicted tissues of patients with mast cell (MC)–dependent chronic allergic diseases. Based on its acute effects on mouse MCs, IL-33 is thought to play a role in the pathogenesis of allergic disease through MC activation. However, the manifestations of prolonged IL-33 exposure on human MC function, which best reflect the conditions associated with chronic allergic disease, are unknown. In this study, we found that long-term exposure of human and mouse MCs to IL-33 results in a substantial reduction of MC activation in response to Ag. This reduction required >72 h exposure to IL-33 for onset and 1–2 wk for reversion following IL-33 removal. This hyporesponsive phenotype was determined to be a consequence of MyD88-dependent attenuation of signaling processes necessary for MC activation, including Ag-mediated calcium mobilization and cytoskeletal reorganization, potentially as a consequence of downregulation of the expression of phospholipase Cγ1 and Hck. These findings suggest that IL-33 may play a protective, rather than a causative, role in MC activation under chronic conditions and, furthermore, reveal regulated plasticity in the MC activation phenotype. The ability to downregulate MC activation in this manner may provide alternative approaches for treatment of MC-driven disease.Keywords
This publication has 37 references indexed in Scilit:
- Amplification of cytokine production through synergistic activation of NFAT and AP‐1 following stimulation of mast cells with antigen and IL‐33European Journal of Immunology, 2011
- Measuring Mast Cell Mediator ReleaseCurrent Protocols in Immunology, 2010
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences of the United States of America, 2010
- Mechanisms of mast cell signaling in anaphylaxisJournal of Allergy and Clinical Immunology, 2009
- The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences of the United States of America, 2009
- New developments in mast cell biologyNature Immunology, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- Synergistic activation of phospholipases Cγ and Cβ: A novel mechanism for PI3K-independent enhancement of FcεRI-induced mast cell mediator releaseCellular Signalling, 2008
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesThe Journal of Experimental Medicine, 2008
- The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase LynBlood, 2007